Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome

Patients with antisynthetase‐positive interstitial lung disease (ILD) alone sometimes develop myositis during follow‐up, but myasthenia gravis (MG) overlapping on antisynthetase syndrome is unusual. A 56‐year‐old woman with ILD and anti‐EJ antibody treated for 8 years developed MG. Physicians should...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Takashi, Kagiyama, Naho, Kawate, Eriko, Odashima, Kyuto, Takaku, Yotaro, Kurashima, Kazuyoshi, Takayanagi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224770/
https://www.ncbi.nlm.nih.gov/pubmed/28096992
http://dx.doi.org/10.1002/ccr3.747
_version_ 1782493417540943872
author Ishiguro, Takashi
Kagiyama, Naho
Kawate, Eriko
Odashima, Kyuto
Takaku, Yotaro
Kurashima, Kazuyoshi
Takayanagi, Noboru
author_facet Ishiguro, Takashi
Kagiyama, Naho
Kawate, Eriko
Odashima, Kyuto
Takaku, Yotaro
Kurashima, Kazuyoshi
Takayanagi, Noboru
author_sort Ishiguro, Takashi
collection PubMed
description Patients with antisynthetase‐positive interstitial lung disease (ILD) alone sometimes develop myositis during follow‐up, but myasthenia gravis (MG) overlapping on antisynthetase syndrome is unusual. A 56‐year‐old woman with ILD and anti‐EJ antibody treated for 8 years developed MG. Physicians should consider myositis and MG when patients develop muscle symptoms during follow‐up.
format Online
Article
Text
id pubmed-5224770
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52247702017-01-17 Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome Ishiguro, Takashi Kagiyama, Naho Kawate, Eriko Odashima, Kyuto Takaku, Yotaro Kurashima, Kazuyoshi Takayanagi, Noboru Clin Case Rep Case Reports Patients with antisynthetase‐positive interstitial lung disease (ILD) alone sometimes develop myositis during follow‐up, but myasthenia gravis (MG) overlapping on antisynthetase syndrome is unusual. A 56‐year‐old woman with ILD and anti‐EJ antibody treated for 8 years developed MG. Physicians should consider myositis and MG when patients develop muscle symptoms during follow‐up. John Wiley and Sons Inc. 2016-12-20 /pmc/articles/PMC5224770/ /pubmed/28096992 http://dx.doi.org/10.1002/ccr3.747 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Ishiguro, Takashi
Kagiyama, Naho
Kawate, Eriko
Odashima, Kyuto
Takaku, Yotaro
Kurashima, Kazuyoshi
Takayanagi, Noboru
Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
title Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
title_full Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
title_fullStr Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
title_full_unstemmed Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
title_short Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐EJ antibody) syndrome
title_sort development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti‐ej antibody) syndrome
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224770/
https://www.ncbi.nlm.nih.gov/pubmed/28096992
http://dx.doi.org/10.1002/ccr3.747
work_keys_str_mv AT ishigurotakashi developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome
AT kagiyamanaho developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome
AT kawateeriko developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome
AT odashimakyuto developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome
AT takakuyotaro developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome
AT kurashimakazuyoshi developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome
AT takayanaginoboru developmentofmyastheniagravis8yearsafterinterstitiallungdiseaseassociatedwithantisynthetaseantiejantibodysyndrome

Ejemplares similares